Delivery Order SPE2DR25D2009-SPE2DR26FJ2U9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams) at a ceiling value of $1,585.92. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a direct procurement under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. No set-aside designation was applied to this award, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams) with a ceiling value of $4,328.64. This firm fixed-price delivery order represents a non-competitive set-aside and is scheduled for completion by August 18, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams) with a ceiling value of $1,964.88. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract represents a small-value pharmaceutical supply transaction under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Albuterol HFA 90 microgram inhalers (8.5 grams) with a ceiling value of $1,201.93. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents no set-aside designation and falls under the company's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Albuterol HFA 90 mcg inhalers in 8.5-gram units, with a ceiling value of $1,026.95 under a firm fixed price contract structure. This delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 20, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Albuterol HFA 90 MCG Inhaler in 8.5GM units, valued at $1,518.96. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $2,063.72 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 mcg inhaler in 8.5 gram units. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office is headquartered. As a non-set-aside contract, this award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, valued at $1,665.03. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, with a completion deadline of September 9, 2025. The award represents a continuation of AmerisourceBergen's substantial role in federal pharmaceutical procurement, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Albuterol HFA 90 MCG inhaler 8.5GM with a ceiling value of $1,223.54. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract has an ultimate completion date of September 5, 2025, and performance will occur at the vendor's Conshohocken facility. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,400.36 to AmerisourceBergen Drug Corp for Albuterol HFA 90 mcg inhalers (8.5 grams) on August 25, 2025, with completion scheduled for August 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ2U9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Albuterol HFA 90 MCG inhalers in 8.5-gram units with a ceiling value of $4,138.56. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion by November 4, 2025, and the work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates extensive experience fulfilling critical medical procurement needs for the Defense Health Agency and other federal healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 11/3/25 |